The nitric oxide synthase brain market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The market growth is driven by the presence of prominent players that are contributing to the market growth. All the major players in the nitric oxide synthase brain market are involved in strategic alliances like acquisitions, partnerships, new product approvals, and collaborations to launch new products to stay competitive in the market. For instance, in January 2022, Eli Lilly and Company Entos Pharmaceuticals’ Fusogenix nucleic acid delivery technology to research, develop and commercialize nucleic acid products targeting the central and peripheral nervous system. technology provides an opportunity for Lilly to access a novel delivery platform technology with the potential to solve a key delivery challenge for many nucleic acid therapeutic modalities. Under the terms of the research and collaboration agreement, Lilly and Entos have agreed to multiple programs focused on the development of proteo-lipid vehicles (PLV) for delivery of therapeutic cargo supplied by Lilly to targets in the central and peripheral nervous systems.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/nitric-oxide-synthase-brain-market
Moreover, in January 2021, Merck announced that the U.S. Food and Drug Administration (FDA) has approved VERQUVO, a soluble guanylate cyclase (sGC) stimulator, to reduce the risk of cardiovascular death and heart failure. The approval of VERQUVO by the FDA, is based on the results of the pivotal Phase 3 VICTORIA trial and follows a priority regulatory review.
Market Coverage
- The market number available for – 2022-2028
- Base year- 2022
- Forecast period- 2022-2028
- Segment Covered-
o By Type
o By End-User
- Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
- Competitive Landscape – Abbexa, Bio-Rad Laboratories, Inc., Bioss, Biovision Inc., Merck KGaA, and many more.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Nitric Oxide Synthase Brain Market Report Segment
By Type
- NNOS
- ENOS
- INOS
By Application
- Research Institute
- Biotechnology
- Pharmaceutical Company
- Others
A full report of Nitric Oxide Synthase Brain Market is available at: https://www.omrglobal.com/industry-reports/nitric-oxide-synthase-brain-market
Nitric Oxide Synthase Brain Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Boster Biological Technology
- BioVision Inc.
- Biorbyt Ltd.
- Bioss Inc.
- Enzo Life Sciences Inc.
- Eli Lilly and Co
- Lifespan BioSciences, Inc.
- Neurophyxia BV
- OriGene Technologies, Inc.
- Proteintech Group, Inc.
- QED Bioscience Inc.
- Rockland Immunochemicals, Inc.
- St John’s Laboratory Ltd.
